B-Cell Receptor-Associated Protein 29 (BCAP29) (Middle Region) Peptide
BCAP29
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN973764
Aperçu rapide pour B-Cell Receptor-Associated Protein 29 (BCAP29) (Middle Region) Peptide (ABIN973764)
Antigène
BCAP29
(B-Cell Receptor-Associated Protein 29 (BCAP29))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
Middle Region
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-BCAP29 antibody (Catalog #: ARP44557_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
BCAP29
(B-Cell Receptor-Associated Protein 29 (BCAP29))
Sujet
BCAP29 may play a role in anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi. BCAP29 may be involved in CASP8-mediated apoptosis.